View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
December 20, 2019updated 15 Dec 2021 9:38am

Acute heart failure in Japan? Expect a lengthy hospital stay

Japan accounted for only 5.68% of hospitalisations for acute heart failure in the eight major markets but had the longest length of hospital stay at 30 days.

By GlobalData Healthcare

Acute heart failure (HF) is a severe condition in which the heart is unable to adequately supply oxygen-rich blood throughout the body, most often requiring hospitalisation and the urgent need for treatment.

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

Globally, the length of stay as a result of an acute heart failure incident varies greatly, with the greatest length of stay seen in Japan.

Figure 1 presents the length of hospital stay after acute HF in days in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China) in 2018.

Based on estimates from GlobalData, in 2018 there were more than 6.7 million hospitalisations for acute heart failure in the 8MM.

Japan accounted for only 5.68% of hospitalisations for acute HF in the 8MM, but had the longest length of hospital stay out of the 8MM at 30 days. In comparison, the US, with nearly three times as many hospitalisations for acute HF, only had a length of stay of four days.

Acute HF most commonly affects adults ages 50 years of age and older and often manifests with symptoms of fatigue, shortness of breath, and coughing and if left untreated in acute situations the consequences can be much more severe. Japan has a significantly higher proportion of elderly people and the high length of stay may be a result of an increased need for care if the average acute HF patient is older than in other markets.

This, coupled with a healthcare system that is structured to provide care for all those in need, results in higher numbers of people seeking care and services being available keeping them there.

Considering the strains all health systems face globally, understanding the burden of acute HF can help to improve outcomes for individuals and the health system overall.

Related reports GlobalData (2019) Heart Failure: Epidemiology Forecast to 2028, December 2019, GDHCER224-19

GlobalData (2019) Heart Failure: Epidemiology Forecast Model to 2028, December 2019, GDHCEM224-19

Related Companies

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management